Granules India informs about company updates

22 Aug 2019 Evaluate

US FDA has completed inspection of the facility of Granules Pharmaceuticals, Inc., a wholly-owned foreign subsidiary of the Company located in Chantilly, Virginia, USA on 21St August 2019 with two minor observations. This is a pre-approval inspection for seven products filed from this facility. Granules Pharmaceuticals, Inc will respond to these observations within the stipulated time period.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

564.95 -6.25 (-1.09%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×